Document headings vary by document type but may contain
                    the following: the agency or agencies that issued and signed a document
the number of the CFR title and the number of each part
                      the document amends, proposes to amend, or is directly
                      related to
the agency docket number / agency internal file number
the RIN which identifies each regulatory action listed in
                      the Unified Agenda of Federal Regulatory and Deregulatory
                      Actions See the
                    Document Drafting Handbook
                    for more details.
 Department of Health and Human Services Food and Drug Administration 21 CFR Parts 510, 520, 522, 524, and 558
[Docket No. FDA-2011-N-0160]
 AGENCY: Food and Drug Administration, HHS.
 ACTION: Final rule; technical amendment.
 SUMMARY: The Food and Drug Administration (FDA) is amending the animal drug regulations by removing those portions that reflect approval of 13 new animal drug applications (NADAs). In a notice published elsewhere in this issue of the 
                        **Federal Register**
                        , FDA is withdrawing approval of these NADAs.
 DATES: This rule is effective April 11, 2011.
 FOR FURTHER INFORMATION CONTACT: John Bartkowiak, Center for Veterinary Medicine (HFV-212), Food and Drug Administration, 7519 Standish Pl., Rockville, MD 20855, 240-276-9079, e-mail: 
                        *john.bartkowiak@fda.hhs.gov.*


SUPPLEMENTARY INFORMATION: The sponsors of the 13 approved NADAs listed in table 1 have requested that FDA withdraw approval because the products are no longer manufactured or marketed. 
 
 Table 1—Voluntary Requests for Withdrawal of Approval of 13 NADAs
Sponsor
NADA No. product
                             (established name of drug)
21 CFR section 
                             affected 
                             (sponsor's drug  
                             labeler code)Roche Vitamins, Inc., 45 Waterview Blvd., Parsippany, NJ 07054-1298
NADA 093-029, UNITOP Cream (cuprimyxin)
524.520 (063238).Quali-Tech Products, Inc., 318 Lake Hazeltine Dr., Chaska, MN 55318
NADA 097-981, TYLAN 40 Sulfa-G Premix (tylosin phosphate/sulfamethazine)
558.630 (016968).Abraxis Pharmaceutical Products, Division of Abraxis Bioscience, 6133 River Rd., suite 500, Rosemont, IL 60018
NADA 100-840, Chorionic Gonadotropin for Injection (chorionic gonadotropin)
522.1081 (063323).Furst-McNess Co., Freeport, IL 61032
NADA 100-991, McNess Custom Premix L200 (tylosin phosphate)
558.625 (010439).Fort Dodge Animal Health, Division of Wyeth Holdings, a wholly owned subsidiary of Pfizer, Inc., 235 East 42d St., New York, NY 10017
NADA 101-079 TRAMISOL-10% Pig Wormer (levamisole)
Not codified (000856).Waterloo Mills Co., 2050 Mitchell Ave., Waterloo, IA 50704
NADA 101-905, Mill Co-Medicator TY-10 (tylosin phosphate)
558.625 (017139).Waterloo Mills Co., 2050 Mitchell Ave., Waterloo, IA 50704
NADA 101-906, Mill Co-Medicator TS-40 Premix (tylosin phosphate/sulfamethazine)
558.630 (017139).Pegasus Laboratories, Inc., 8809 Ely Rd., Pensacola, FL 32514
NADA 102-824,Phenylbutazone Tablets (phenylbutazone)
520.1720a (055246).Wendt Laboratories, Inc., 100 Nancy Dr., Belle Plaine, MN 56011
NADA 108-487, DEC Tabs (diethylcarbamazine citrate)
520.622a (015579).Wendt Laboratories, Inc., 100 Nancy Dr., Belle Plaine, MN 56011
NADA 108-863, DEC Chewable Tabs (diethylcarbamazine citrate)
520.622c (015579).Furst-McNess Co., Freeport, IL 61032
NADA 140-820, TYLAN 40 Sulfa-G Premix (tylosin phosphate/sulfamethazine)
558.630 (010439).Furst-McNess Co., Freeport, IL 61032
NADA 140-825, BANMINTH Intermediate Premix (pyrantel tartrate)
558.485 (010439).Hess & Clark, Inc., 944 Nandino Blvd., Lexington, KY 40511
NADA 140-910, NFZ Wound Powder (nitrofurazone)
524.1580c (050749).
 In a notice published elsewhere in this issue of the 
                    **Federal Register**
                    , FDA gave notice that approval of NADAs 93-029, 97-981, 100-840, 100-991, 101-079, 101-905, 101-906, 102-824, 108-487, 108-863, 140-820, 140-825, and 140-910, and all supplements and amendments thereto, is withdrawn, effective April 11, 2011. As provided in the regulatory text of this document, the animal drug regulations are amended to reflect these withdrawals of approval and a current format. Following these changes of sponsorship, Abraxis Pharmaceutical Products, Furst-McNess Co., Roche Vitamins, Inc., Waterloo Mills Co., and Wendt Laboratories, Inc., are no longer the sponsors of an approved application. Accordingly, 21 CFR 510.600(c) is being amended to remove the entries for these firms. This rule does not meet the definition of “rule” in 5 U.S.C. 804(3)(A) because it is a rule of “particular applicability.” Therefore, it is not subject to the congressional review requirements in 5 U.S.C. 801-808. List of Subjects 21 CFR Part 510 Administrative practice and procedure
Animal drugs
Labeling
Reporting and recordkeeping requirements 21 CFR Parts 520, 522, and 524 Animal drugs 21 CFR Part 558 Animal drugs
Animal feeds
 Therefore, under the Federal Food, Drug, and Cosmetic Act and under authority delegated to the Commissioner of Food and Drugs and redelegated to the Center for Veterinary Medicine, 21 CFR parts 510, 520, 522, 524, and 558 are amended as follows: PART 510—NEW ANIMAL DRUGS
 1.The authority citation for 21 CFR part 510 continues to read as follows: Authority:
                        21 U.S.C. 321, 331, 351, 352, 353, 360b, 371, 379e. § 510.600
 2.In § 510.600, in the table in paragraph (c)(1), remove the entries for “Abraxis Pharmaceutical Products”, “Furst-McNess Co.”, “Roche Vitamins, Inc.”, “Waterloo Mills Co.”, and “Wendt Laboratories, Inc.”; and in the table in paragraph (c)(2), remove the entries for “010439”, “015579”, “017139”, “063238”, and “063323”. PART 520—ORAL DOSAGE FORM NEW ANIMAL DRUGS
 3.The authority citation for 21 CFR part 520 continues to read as follows: Authority:
                        21 U.S.C. 360b. 4.In § 520.622a, remove and reserve paragraph (a)(1); in paragraph (a)(5), remove “000081' and in its place add “No. 000061”; and revise paragraph (b)(2) to read as follows: § 520.622a
  
 (b) * * * (2) 
                            *Limitations.*
                             Federal law restricts this drug to use by or on the order of a licensed veterinarian.
 5.In § 520.622c, remove and reserve paragraph (b)(1); remove reserved paragraph (b)(7); and revise paragraph (c)(3) to read as follows: § 520.622c
  
 (c) * * * (3) 
                            *Limitations.*
                             Federal law restricts this drug to use by or on the order of a licensed veterinarian.
 § 520.1720a
 6.In § 520.1720a, remove and reserve paragraph (b)(4). PART 522—IMPLANTATION OR INJECTABLE DOSAGE FORM NEW ANIMAL DRUGS
 7.The authority citation for 21 CFR part 522 continues to read as follows: Authority:
                        21 U.S.C. 360b. § 522.1081
 8.In paragraph (b)(2) of § 522.1081, remove “Nos. 058639 and 063323” and in its place add “No. 058639”. PART 524—OPHTHALMIC AND TOPICAL DOSAGE FORM NEW ANIMAL DRUGS
 9.The authority citation for 21 CFR part 524 continues to read as follows: Authority:
                        21 U.S.C. 360b. § 524.520
 10.Remove § 524.520. § 524.1580c
 11.In paragraph (b) of § 524.1580c, remove “Nos. 000010, 000069, and 050749” and in its place add “Nos. 000010 and 000069”. PART 558—NEW ANIMAL DRUGS FOR USE IN ANIMAL FEEDS
 12.The authority citation for 21 CFR part 558 continues to read as follows: Authority:
                        21 U.S.C. 360b, 371. § 558.485
 13.In § 558.485, in paragraph (b)(3), remove “010439”. § 558.625
 14.In § 558.625, remove and reserve paragraphs (b)(42) and (b)(45). § 558.630
 15.In § 558.630, remove and reserve paragraph (b)(4); and in paragraph (b)(5), remove “010439,” and “016968,”. Dated: March 25, 2011. Leslie Kux, Acting Assistant Commissioner for Policy.


[FR Doc. 2011-7560 Filed 3-30-11; 8:45 am] BILLING CODE 4160-01-P